Innovative Pharma Pricing & Market Access Strategies Summit

This premier B2B event will enable the participants to learn about the latest developments and provide the appropriate platform for dialogue and networking with peers involved in Pharma Pricing & Market Access.

The Summit will shed light on current Pharma Pricing & Market Access challenges, best practice, new solutions, and trends of today and those we anticipate in the future in Pharma Pricing & Market Access.

At this Summit you will have an unprecedented opportunity to learn from some of the most renowned experts in the field that will enable you to put into practice whta you learnt in the future, resulting in significant advantages that will enable you to overtake your competitors in the market.

Key Practical Learning Points of the Summit:

  • The impact of pricing policies on Pharmaceutical Innovation
  • Biosimilars and their influence on pricing and reimbursement
  • Pricing strategy: Price premiums vs discounts: What’s best?
  • Balancing value & affordability for a new orphan product
  • Improving value proposition with HTA
  • Development of alternative payment models
  • Persuading payers for expensive new treatments with RWE
  • Fostering a successful tendering management strategy
  • Ensuring market access success
  • Maximizing your market access strategies by knowing regulatory trends
  • Patient-centered approaches that help advance market access goals
  • The contribution of marketing intelligence to pharmaceutical market access 

Who Should Attend:

CEOs / Presidents / MDs, CCOs/CMOs/CDOs, Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:

  • Business Development
  • Marketing
  • Sales
  • Pricing
  • Market Access
  • Medical Director
  • Marketing Intelligence
  • Drug Pricing
  • Product Launch
  • Health Economics
  • Pricing Policy
  • Product Reimbursement
  • Health Technology Assessment
  • Real World Evidence
  • Health Informatics
  • Data Sciences
  • Value Strategy
  • P&MA
  • Tendering

From Industries Including:

  • Biotechnology 
  • Pharmaceuticals
Media partners